RespireRx Pharmaceuticals Inc (RSPI): Big Pharma Company may be able to Buyout...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

RespireRx Pharmaceuticals Inc (RSPI)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	52
Posts	3024
Boards Moderated	9
Alias Born	01/28/2001

Re: StocktonCA post# 45276

Thursday, 05/02/2024 11:27:07 PM

Thursday, May 02, 2024 11:27:07 PM

Big Pharma Company may be able to Buyout this company for $2.50- $5.00/Share buy why would they today?
They can just start loading up shares now for pennies on the dollar if they wanted.
Let them help run up this stock where it should be.

Drug companies are not buying out drug companies in 2024, or are they!

2024 Pharmaceutical Industry Mergers & Acquisitions Roundup

Ampersand Capital Partners—Biologos LLC. ...
AstraZeneca—Fusion Pharmaceuticals. ...
Bristol Myers Squibb—Karuna Therapeutics. ...
AstraZeneca—Amolyt Pharma. ...
Novartis—IFM Due. ...
Johnson & Johnson—Ambrx. ...
Eilean Therapeutics—Ness Therapeutics. ...
CoreRx—Societal CDMO.

Is there big money in drugs?
Here are the 10 projected best-selling drugs in 2024 and their expected global sales:
Keytruda (Merck) — $27.2 billion.
Ozempic (Novo Nordisk) — $16.1 billion.
Dupixent (Sanofi) — $13.5 billion.
Eliquis (Bristol Myers Squibb) — $13.3 billion.
Biktarvy (Gilead) — $12.6 billion.
Darzalex (Johnson & Johnson) — $12 billion.

Others
https://seekingalpha.com/article/4679123-3-potential-biotech-buyout-targets-in-2024

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent RSPI News

Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:05:55 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:15:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 12:52:24 PM

More RSPI News

InvestorsHub NewsWire

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM

Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM

Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM

Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM

Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow